✳ GrantAtlasSign in ↗
← All opportunities

Posted opportunity — confirm at source

NIH Small Business Innovation Research (SBIR) Phase IIB Strategic Breakthrough Award (Parent [R44] Clinical Trial Optional)

National Institutes of Health · PA-27-101

Award range

See source for award amount

Deadline

2029-04-05-00-00-00

Confirm exact timezone in the announcement.
Eligible applicants

Small businesses

Geographic eligibility and all attachment-specific conditions require review of the original announcement.

Eligibility details

Only United States small business concerns (SBCs) that have previously received an NIH SBIR or STTR Phase II award are eligible to submit applications for this opportunity. Only one NIH Phase IIB Strategic Breakthrough award is allowed per project. This NOFO supports Renewal/Resubmission "Type 2" Applications from recipients with NIH Phase II SBIR/STTR awards that are submitted within the first six due dates following the expiration of their budget period. Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility.Foreign Organizations/International Collaborations:Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.Unfunded international collaborations or unfunded foreign components, as defined in the NIH Grants Policy Statement, may be allowed.

Matching funds & resources

Source matching-funds field: Required.

Matching funds and leveraged resources are different requirements. Read the description and reviewed rules below before determining resource commitments.

About this opportunity

The NIH Phase IIB Strategic Breakthrough award bridges the funding gap between the end of a Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Phase II award and commercialization. The Phase IIB Strategic Breakthrough provides previously funded NIH SBIR or STTR projects additional support for later-stage research and development (R&D).

Funding geography: Not specified — review source. A funder’s address does not establish eligibility.

Review original source ↗

Funding instrument: Grant. Issuing jurisdiction: Federal. This is not a geographic eligibility determination.

Source fields and evidence

id: 359758
Source ↗ · id

opportunityNumber: PA-27-101
Source ↗ · opportunityNumber

opportunityTitle: NIH Small Business Innovation Research (SBIR) Phase IIB Strategic Breakthrough Award (Parent [R44] Clinical Trial Optional)
Source ↗ · opportunityTitle

revision: 6
Source ↗ · revision

agencyDetails: {"code":"NIH","seed":"HHS-NIH11","agencyName":"National Institutes of Health","agencyCode":"HHS-NIH11","topAgencyCode":"HHS"}
Source ↗ · agencyDetails

owningAgencyCode: HHS-NIH11
Source ↗ · owningAgencyCode

cfdas: [{"id":429878,"opportunityId":359758,"cfdaNumber":"93.233","programTitle":"National Center on Sleep Disorders Research"},{"id":429882,"opportunityId":359758,"cfdaNumber":"93.242","programTitle":"Mental Health Research Grants"},{"id":429870,"opportunityId":359758,"cfdaNumber":"93.273","programTitle":"Alcohol Research Programs"},{"id":429887,"opportunityId":359758,"cfdaNumber":"93.307","programTitle":"Minority Health and Health Disparities Research"},{"id":432681,"opportunityId":359758,"cfdaNumber":"93.313","programTitle":"NIH Office of Research on Women's Health"},{"id":432680,"opportunityId":359758,"cfdaNumber":"93.350","programTitle":"National Center for Advancing Translational Sciences"},{"id":432679,"opportunityId":359758,"cfdaNumber":"93.351","programTitle":"Research Infrastructure Programs"},{"id":429879,"opportunityId":359758,"cfdaNumber":"93.393","programTitle":"Cancer Cause and Prevention Research"},{"id":429875,"opportunityId":359758,"cfdaNumber":"93.394","programTitle":"Cancer Detection and Diagnosis Research"},{"id":429885,"opportunityId":359758,"cfdaNumber":"93.395","programTitle":"Cancer Treatment Research"},{"id":429863,"opportunityId":359758,"cfdaNumber":"93.837","programTitle":"Cardiovascular Diseases Research"},{"id":429884,"opportunityId":359758,"cfdaNumber":"93.838","programTitle":"Lung Diseases Research"},{"id":429877,"opportunityId":359758,"cfdaNumber":"93.839","programTitle":"Blood Diseases and Resources Research"},{"id":429873,"opportunityId":359758,"cfdaNumber":"93.840","programTitle":"Translation and Implementation Science Research for Heart, Lung, Blood Diseases, and Sleep Disorders"},{"id":429881,"opportunityId":359758,"cfdaNumber":"93.847","programTitle":"Diabetes, Digestive, and Kidney Diseases Extramural Research"},{"id":432683,"opportunityId":359758,"cfdaNumber":"93.853","programTitle":"Extramural Research Programs in the Neurosciences and Neurological Disorders"},{"id":432682,"opportunityId":359758,"cfdaNumber":"93.855","programTitle":"Allergy and Infectious Diseases Research"},{"id":432684,"opportunityId":359758,"cfdaNumber":"93.859","programTitle":"Biomedical Research and Research Training"},{"id":429872,"opportunityId":359758,"cfdaNumber":"93.865","programTitle":"Child Health and Human Development Extramural Research"},{"id":429865,"opportunityId":359758,"cfdaNumber":"93.866","programTitle":"Aging Research"},{"id":429883,"opportunityId":359758,"cfdaNumber":"93.867","programTitle":"Vision Research"},{"id":433703,"opportunityId":359758}]
Source ↗ · cfdas

applicantTypes: [{"id":"23","description":"Small businesses"}]
Source ↗ · applicantTypes

applicantEligibilityDesc: Only United States small business concerns (SBCs) that have previously received an NIH SBIR or STTR Phase II award are eligible to submit applications for this opportunity. Only one NIH Phase IIB Strategic Breakthrough award is allowed per project. This NOFO supports Renewal/Resubmission "Type 2" Applications from recipients with NIH Phase II SBIR/STTR awards that are submitted within the first six due dates following the expiration of their budget period. Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility.Foreign Organizations/International Collaborations:Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.Unfunded international collaborations or unfunded foreign components, as defined in the NIH Grants Policy Statement, may be allowed.
Source ↗ · applicantEligibilityDesc

fundingInstruments: [{"id":"G","description":"Grant"}]
Source ↗ · fundingInstruments

fundingActivityCategories: [{"id":"HL","description":"Health"}]
Source ↗ · fundingActivityCategories

awardFloor: none
Source ↗ · awardFloor

awardCeiling: none
Source ↗ · awardCeiling

responseDate: Apr 05, 2029 12:00:00 AM EDT
Source ↗ · responseDate

responseDateStr: 2029-04-05-00-00-00
Source ↗ · responseDateStr

costSharing: true
Source ↗ · costSharing

lastUpdatedDate: Jun 01, 2026 12:56:46 PM EDT
Source ↗ · lastUpdatedDate

status: posted
Source ↗ · oppHits[id=359758].oppStatus

Related collections: Health funding opportunities · Funding listings with small-business applicant categories · NIH research funding ·

Source retrieved 10/15/2026 · Revision 6. Always confirm current requirements and dates with the funder. Structured source fields are checked; this is not a determination that every applicant qualifies.

Build your funding pipeline.

Save opportunities, filter by fit, and export your deadlines with membership.

View plans from $49/month ↗